Eminent pathologist Richard Scolyer reveals heartbreaking cancer update months after experimental immunotherapy

Eminent pathologist Richard Scolyer reveals heartbreaking cancer update months after experimental immunotherapy

Acclaimed melanoma expert and former Australian of the Year Professor Richard Scolyer has shared a heartbreaking update on his battle with brain cancer – revealing the disease is advancing again. Professor Scolyer, 58, was diagnosed with the aggressive and incurable glioblastoma in 2023 and initially given just eight months to live. However, after undergoing experimental … Read more

Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies

Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh Therapies

When a person develops solid tumors in the stomach or esophagus or rectum, oncologists know how to treat them. But the cures often come with severe effects on quality of life. That can include removal of the stomach or bladder, a permanent colostomy bag, radiation that makes patients infertile and lasting damage from chemotherapy. So … Read more

Lupus Patients Go Into Remission in ‘Spectacular’ Immunotherapy Trial

Lupus Patients Go Into Remission in ‘Spectacular’ Immunotherapy Trial

Five seriously ill lupus patients have seen their disease driven into remission after a single infusion of modified immune cells, in a small trial that borrows from cancer therapy to harness patients’ own cells to treat the autoimmune condition. Scientists are calling the results “spectacular” and “incredibly exciting”, saying the findings may herald a new … Read more

Five People With Lupus Went Into Complete Remission After Immunotherapy

Five People With Lupus Went Into Complete Remission After Immunotherapy

Joint pain is a common lupus symptom, but the chronic condition can affect nearly every organ in the body. Image: Shutterstock (Shutterstock) Scientists in Germany may have demonstrated a new way to treat and possibly even cure the chronic condition lupus. In a study out Thursday, the team describes how patients given a form of … Read more